Neonatal diabetes mellitus: Insulin pump as an alternative management strategy

Journal of Paediatrics and Child Health

Volumn 41, Issue 9-10, 2005, Pages 522-526

  Bharucha, Tara ^a,b   Brown, Justin ^a,b   McDonnell, Ciara ^a,b   Gebert, Robecca ^a,b   McDougall, Peter ^b   Cameron, Fergus ^a,b   Werther, George ^a,b   Zacharin, Margaret ^a,b  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Continuous subcutaneous insulin infusion diabetes mellitus; Management guidelines; Newborn

Indexed keywords

DILUENT; INSULIN; INSULIN LISPRO; ISOPHANE INSULIN; ND 800; NEUTRAL INSULIN; SUCROSE; SYRUP BP; ANTIDIABETIC AGENT;

BLOOD GLUCOSE MONITORING; CASE REPORT; CLINICAL FEATURE; DIABETES MELLITUS; DOSE CALCULATION; DRUG ABSORPTION; DRUG EFFICACY; FEEDING; FEMALE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INFUSION SYSTEM; INSULIN INFUSION; INSULIN PUMP; INSULIN TREATMENT; INTRAUTERINE GROWTH RETARDATION; MALE; NEWBORN; NEWBORN DIABETES MELLITUS; NEWBORN DISEASE; PRIORITY JOURNAL; REVIEW; SUBCUTANEOUS FAT; ARTICLE; METABOLISM; PREMATURITY; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

DIABETES MELLITUS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INFANT, NEWBORN; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; PREMATURE BIRTH; TREATMENT OUTCOME;

EID: 33644818105     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2005.00696.x     Document Type: Review

References (28)

1. Shield JPH, Gardner RJ, Wadsworth EJK et al. Aetiopathology and genetic basis of neonatal diabetes. Arch. Dis. Child. 1997 76 : F39 42.
2. Von Muhlendal KE, Herkenhoff H. Long-term course of neonatal diabetes. N. Engl. J. Med. 1995 333 : 704 8.
3. Marquis E, Robert JJ, Bouvattier C, Bellane-Chantelot C, Junien C, Diatloff-Zito C. Major difference in aetiology and phenotypic abnormalities between transient and permanent neonatal diabetes. J. Med. Genet. 2002 39 (5 370 4.
4. Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL, Habener JF. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat. Genet. 1997 15 : 106 10.
5. Delepine M, Nicolino M, Barrett T. EIF2AK3, encoding translation initiation factor-2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat. Genet. 2000 25 : 406 9.
6. Njolstad PR, Sovik O, Cuesta-Munoz A et al. Neonatal diabetes due to complete glucokinase deficiency. N. Engl. J. Med. 2001 344 : 1588 92.
7. Gloyn AL, Ewan DP, Pearson ER et al. Activating mutations in the gene encoding the ATP-sensitive potassium channel subunit Kir6.2 and permanent neonatal diabetes. N. Engl. J. Med. 2004 350 : 1838 49.
8. Sagen JV, Raeder H, Hathout E et al. Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: Patient characteristics and initial response to sulfonylurea therapy. Diabetes 2004 53 (10 2713 18.
9. Zung A, Glaser B, Nimri R, Zadik Z. Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2. J. Clin. Endocrinol. Metab. 2004 89 (11 5504 7.
10. Menon PS, Khatwa UA. Diabetes mellitus in newborns and infants. Ind. J. Pediatr. 2000 67 : 443 8.
11. Gentz JCH, Cornblath M. Transient diabetes of the newborn. Adv. Pediatr. 1969 16 : 345 63.
12. Peterson S, Gotfredson A, Knudsen FU. Lean body mass in small for gestational age and appropriate for gestational age infants. J. Pediatr. 1988 113 (5 886 9.
13. Sindelka G, Heineman L, Berger M, Frenck W, Chantelau E. Effect of insulin concentration, subcutaneous fat thickness and skin temperature on subcutaneous insulin absorption in healthy subjects. Diabetologia 1994 37 (4 377 80.
14. Mitamura R, Kimura H, Muarakami Y, Nagaya K, Makita Y, Okuno A. Ultralente insulin treatment of transient neonatal diabetes neonatal diabetes mellitus. J. Pediatr. 1996 128 (2 268 70.
15. Sodoyez-Goffaux F, Sodoyez JC. Transient diabetes mellitus in the neonate. J. Pediatr. 1977 91 : 395 9.
16. Takahashi S, Kajino M, Inyaku F, Yano K. Transient neonatal diabetes mellitus with hydrops fetalis and macroglossia. Acta Neonat. Jpn. 1993 29 : 285 9.
17. Hewson M, Nawadra V, Oliver J, Odgers C, Plummer J, Simmer K. Insulin infusions in the neonatal unit: Delivery variation due to adsorption. J. Paediatr. Child. Health 2000 36 (3 216 20.
18. Battin M, Yong C, Phang M, Daaboul J. Transient neonatal diabetes and macroglossia. J. Perinatol. 1996 16 (4 288 91.
19. Carretero Bellon J, Moralejo Benitez J, Olive Vilella R, Collell Hernandez R, Cardona Barberan A, Closa Monasterolo R. [Transitory neonatal diabetes]. An. Esp. Pediatr. 2001 54 (4 394 6.
20. Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years: Evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 2002 25 (3 593 8.
21. Weintrob N, Benzaquen H, Galatzer A et al. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: A randomised open crossover trial. Pediatrics 2003 112 : 559 64.
22. Rami B, Nachbaur E, Waldhoer T, Schober E. Continuous subcutaneous insulin infusion in toddlers. Eur. J. Pediatr. 2003 162 (10 721 2.
23. Colquitt J, Royle P, Waugh N. Are analogue insulins better than soluble in continuous subcutaneous insulin infusion? Results of a meta-analysis. Diabet. Med. 2003 20 (10 863 6.
24. Bode BW. Establishing and verifying basal rates. In : Frederickson L, ed. The Insulin Pump Therapy Book: Insights from the Experts. Sylmar, CA : Minimed Technologies, 1995 48 56.
25. Conrad CC, McGrath MT, Gitelman SE. Transition from multiple daily injections to continuous subcutaneous insulin infusion in type 1 diabetes mellitus. J. Pediatr. 2002 140 : 235 40.
26. Northam EA, Anderson PJ, Werther GA, Warne GL, Adler RG, Andrewes D. Neuropsychological complications of IDDM in children 2 years after disease onset. Diabetes Care 1998 21 (3 379 84.
27. Kerouz N, el-Hayek R, Langhough R, MacDonald MJ. Insulin doses in children using conventional therapy for insulin dependent diabetes. Diabetes Res. Clin. Pract. 1995 29 (2 113 20.
28. Wintergerst KA, Hargadon S, Hsiang HY. Continuous subcutaneous infusion in neonatal diabetes mellitus. Ped. Diabetes 2004 5 : 202 6.